{"ticker": {"uuid": "3b1caa76-a53b-4b8c-bbc4-9a808e8201d0", "symbol": "002252", "name": "Shanghai RAAS Blood Products Co., Ltd.", "exchange": "SHZ", "country": "CN", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "ETFs Investing in Shanghai RAAS Blood Products Co., Ltd. Class A Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiY0FVX3lxTE1sMURXRWZKVEl0MUYzdTRxZWo2RU8zdVNSZjJpZXU4dTBHYmNRMDlRelN0eDYtdVlGTjFMUks2SE05WTJUMThlNVMtZVM2Vmc4ZWpVeFNlWlJNWkp6ak9wYUdYbw?oc=5", "source_name": "TradingView", "published_at": "2026-07-21T02:50:29+00:00", "published_display": "21 Jul 2026 02:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Shanghai RAAS Blood Products Co., Ltd. Class A \u2013 SZSE:002252", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNMzFLTS01bHVncENkZTlHQ05DdklhSkJ0NEplWVNXRnhGcWhXTWpjWEFSakl3NlI1NHpkQnlXWlBMZ1FNc1BHNWhvcDFZTHNFU012MFBDUGlpQjVVT0ZfWENmUFVHdnBlOS1aSVlhVFJPblVPQmJHeGIxWnRyNmFuV3RqMm1zN3k5clZ5SGRNN1JYd0F1dnZPdVF3Uno0TDF6WWkyZmFjdzZVdHhLdmc?oc=5", "source_name": "TradingView", "published_at": "2026-07-05T01:55:18+00:00", "published_display": "05 Jul 2026 01:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Grifols shares soar after sale of 20% of Shanghai RAAS for $1.8 bln", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQc2N6THJEOVhqNzMtcHI1bEFzOVdfTy16RmxBd2QyTnc4VWpQWVV4em1hWGNSblpYUl9VenZTTkd1eWRxWXhxekRCZzVKXzYzZXRZcjl4WG9OeWwzcUZIdFI1MElxUjhXQUxHMjVGa1ZxbjZLcDRRTDYtZmhnRndCbDQ3ZmRWMTNvMGhoY1lGeTFDenlaTzNFbVlBbE54R0xuM3NTMkFCQQ?oc=5", "source_name": "Reuters", "published_at": "2023-12-29T08:00:00+00:00", "published_display": "29 Dec 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Grifols\u2019 Shanghai RAAS acquisition: A share swap deal first", "summary": "", "url": "https://news.google.com/rss/articles/CBMiYEFVX3lxTE9MdG0tYXJQWGxXbWFGaXp3UkVNOGpqT0VfdmUyTWJiSHNNRUdReEszZjJwN1ZXWTBVMTk3SWZJTDVZYno5a0dmZHJzMzdhVjZPdk9VY09LQ0xmVExMZU02YQ?oc=5", "source_name": "Law.asia", "published_at": "2021-02-04T08:00:00+00:00", "published_display": "04 Feb 2021 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China Biologic Products, Inc.: Exhibit 99.2 - Prepared by TNT Filings Inc.", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxPeldsVlNZLVRzVjFtMXB2WEpsUXM4QUJTMjVVZ1dwRU4tX3ZkVzNXOWlJSGFjazdxYmw3UzFLanlrT2VfUDRuMkctVmJxUkJxalFlVmgwMDJDN0ZBMi1Td0pLbnNzYW1BTnAzMm5SdWFiM2V0NU8tc3NlNG1BOC1SdGJtRHJOeGoteTdpVWpETXdSZw?oc=5", "source_name": "SEC.gov", "published_at": "2016-06-18T05:50:56+00:00", "published_display": "18 Jun 2016 05:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "ETFs Investing in Shanghai RAAS Blood Products Co., Ltd. Class A Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiY0FVX3lxTE1sMURXRWZKVEl0MUYzdTRxZWo2RU8zdVNSZjJpZXU4dTBHYmNRMDlRelN0eDYtdVlGTjFMUks2SE05WTJUMThlNVMtZVM2Vmc4ZWpVeFNlWlJNWkp6ak9wYUdYbw?oc=5", "source_name": "TradingView", "published_at": "2026-07-21T02:50:29+00:00", "published_display": "21 Jul 2026 02:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Shanghai RAAS Blood Products Co., Ltd. Class A \u2013 SZSE:002252", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNMzFLTS01bHVncENkZTlHQ05DdklhSkJ0NEplWVNXRnhGcWhXTWpjWEFSakl3NlI1NHpkQnlXWlBMZ1FNc1BHNWhvcDFZTHNFU012MFBDUGlpQjVVT0ZfWENmUFVHdnBlOS1aSVlhVFJPblVPQmJHeGIxWnRyNmFuV3RqMm1zN3k5clZ5SGRNN1JYd0F1dnZPdVF3Uno0TDF6WWkyZmFjdzZVdHhLdmc?oc=5", "source_name": "TradingView", "published_at": "2026-07-05T01:55:18+00:00", "published_display": "05 Jul 2026 01:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Grifols shares soar after sale of 20% of Shanghai RAAS for $1.8 bln", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQc2N6THJEOVhqNzMtcHI1bEFzOVdfTy16RmxBd2QyTnc4VWpQWVV4em1hWGNSblpYUl9VenZTTkd1eWRxWXhxekRCZzVKXzYzZXRZcjl4WG9OeWwzcUZIdFI1MElxUjhXQUxHMjVGa1ZxbjZLcDRRTDYtZmhnRndCbDQ3ZmRWMTNvMGhoY1lGeTFDenlaTzNFbVlBbE54R0xuM3NTMkFCQQ?oc=5", "source_name": "Reuters", "published_at": "2023-12-29T08:00:00+00:00", "published_display": "29 Dec 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Grifols\u2019 Shanghai RAAS acquisition: A share swap deal first", "summary": "", "url": "https://news.google.com/rss/articles/CBMiYEFVX3lxTE9MdG0tYXJQWGxXbWFGaXp3UkVNOGpqT0VfdmUyTWJiSHNNRUdReEszZjJwN1ZXWTBVMTk3SWZJTDVZYno5a0dmZHJzMzdhVjZPdk9VY09LQ0xmVExMZU02YQ?oc=5", "source_name": "Law.asia", "published_at": "2021-02-04T08:00:00+00:00", "published_display": "04 Feb 2021 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China Biologic Products, Inc.: Exhibit 99.2 - Prepared by TNT Filings Inc.", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxPeldsVlNZLVRzVjFtMXB2WEpsUXM4QUJTMjVVZ1dwRU4tX3ZkVzNXOWlJSGFjazdxYmw3UzFLanlrT2VfUDRuMkctVmJxUkJxalFlVmgwMDJDN0ZBMi1Td0pLbnNzYW1BTnAzMm5SdWFiM2V0NU8tc3NlNG1BOC1SdGJtRHJOeGoteTdpVWpETXdSZw?oc=5", "source_name": "SEC.gov", "published_at": "2016-06-18T05:50:56+00:00", "published_display": "18 Jun 2016 05:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 61, "total_relevant": 5, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 5, "score": 50, "total": 5, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 76, "events": [{"event": "general", "label": "Market update", "weight": 2.55, "count": 4}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 5.09, "latest_week": "2026-07-17", "one_week_move": 11.1, "four_week_move": 10.2, "twelve_week_move": -7.5, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.672518, "market_dynamics_buy_signal": false, "relative_strength": -18.52165, "fair_value_gap": -25.0, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 47.5569, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+11.1% over one week, +10.2% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 57, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 2}, {"label": "Reuters", "count": 1}, {"label": "Law.asia", "count": 1}, {"label": "SEC.gov", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 5}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 4}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "76/100 classification confidence."}, {"label": "Company focus", "value": "5", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+11.1% over one week, +10.2% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "ETFs Investing in Shanghai RAAS Blood Products Co., Ltd. Class A Stocks"}], "updated_at": "2026-07-21T21:13:27.368921+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}